Linomide induces apoptotic death of cortical CD4/CD8 double positive thymocytes and thymic atrophy by a corticosteroid-independent pathway.
Linomide is a synthetic immunomodulator which was shown to protect animals against a wide range of experimental autoimmune diseases. In this study we have investigated the effects of Linomide on the thymus in an effort to elucidate the mechanisms by which this immunomodulator suppresses autoimmune reactivity. Normal or adrenalectomized SJL/J mice were treated orally for 10 days with linomide (80 mg/kg/day). Thymocytes were tested by FACS for the analysis of the CD4 and CD8 markers and TCR expression on their surface. Thymuses from these animals were examined for size and cellularity and immunohistopathologically for the detection of apoptosis and for the expression of the markers CD4 and CD8. A significant reduction in the thymus size and cellularity was observed in mice treated with Linomide, starting from day 3 after treatment, accompanied by an enhanced apoptotic death of cortical thymocytes, which was first noted on day 1 of treatment and peaked on day 3. FACS analysis and immunohistochemistry revealed a significant depletion of the CD4(+)/CD8(+) (double positive) cells with a parallel relative increase of the more mature, medullar, single positive, lymphocytes. These effects on the thymus were not mediated through a corticosteroid-dependent pathway, and were also observed in adrenalectomized and Linomide-treated animals. These observations may be of importance for the clarification of the role of thymus in autoimmunity and the possible ways for immune intervention with immunomodulators like Linomide at this level.
Arbel
I
I
Laboratory of Neuroimmunology, Hadassah, Hebrew University Hospital, Jerusalem, IL-91120, Israel.
Chezen
E
E
Abramsky
O
O
Karpati
T
T
Ovadia
H
H
Mizrachi-Koll
R
R
Karussis
D
D
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000305:Adrenal Cortex Hormones / Q000502:physiology*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D001284:Atrophy / Q000139:chemically induced; D015551:Autoimmunity / Q000187:drug effects; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000473:pathology; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects* / Q000473:pathology; D005260:Female; D006912:Hydroxyquinolines / Q000494:pharmacology*; D051379:Mice; D008815:Mice, Inbred Strains; D013950:Thymus Gland / Q000187:drug effects* / Q000276:immunology / Q000473:pathology*
D000276:Adjuvants, Immunologic; D000305:Adrenal Cortex Hormones; D006912:Hydroxyquinolines; C045282:roquinimex